Sarepta Therapeutics is a biopharmaceutical company developing RNA-targeted therapeutics that addres serious and life-threatening diseases including Duchenne muscular dystrophy and infectious diseases such as influenza, and the Ebola virus.
2025/11/2 15:19:12
(SRPT:NASDAQ)
Streetwise Reports Articles